Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,292.20    -19.20 (-1.46%)
Bid:
1,290.80
Ask:
1,291.00
Spread: 0.20 (0.015%)
Market Cap: £221.59b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Transaction in Own Shares

16 Oct 2023 17:59

RNS Number : 2902Q
HSBC Holdings PLC
16 October 2023
Ā 

HSBC HOLDINGS PLC

16 October 2023

Transaction in own shares

Ā 

HSBC Holdings plc ("HSBC" or the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of US$0.50 from Merrill Lynch International ("Merrill Lynch") as part of its buy-back announced on 2 August 2023.

UK Venues

Date of purchase:

16 October 2023

Number of ordinary shares of US$0.50 each purchased:

2,055,526

Highest price paid per share:

Ā£6.5360

Lowest price paid per share:

Ā£6.4920

Volume weighted average price paid per share:

Ā£6.5168

Ā 

All repurchases on the London Stock Exchange, Cboe Europe Limited (through the BXE and CXE order books) and/or Turquoise ("UK Venues") are implemented as "on Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and as "market purchases" for the purposes of the Companies Act 2006.

Hong Kong Stock Exchange

Date of purchase:

16 October 2023

Number of ordinary shares of US$0.50 each purchased:

1,493,200

Highest price paid per share:

HK$62.1000

Lowest price paid per share:

HK$61.7000

Volume weighted average price paid per share:

HK$61.8701

All repurchases on The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") are "off market" for the purposes of the Companies Act 2006 but are transactions which occur "on Exchange" for the purposes of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and which constitute an "on-market share buy-back" for the purposes of the Codes on Takeovers and Mergers and Share Buy-backs.

Since the commencement of the buy-back announced on 2 August 2023, the Company has repurchased 235,652,580Ā ordinary shares for a total consideration of approximately US$1,821.2m.

Following the cancellation of the shares repurchased on the UK Venues, the Company will have 19,842,267,869Ā ordinary shares in issue, including 325,273,407 ordinary shares of US$0.50 each which are held in treasury. Therefore, the total voting rights in the Company will be 19,516,994,462. Cancellation of the shares repurchased on the Hong Kong Stock Exchange takes longer than those repurchased on the UK Venues and a further announcement of total voting rights will be made once those shares have been cancelled.

This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by Merrill Lynch on behalf of the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/2902Q_1-2023-10-16.pdf

This announcement will also be available on HSBC's website at www.hsbc.com/sea

Enquiries to:

Lee DavisCorporate Governance & Secretariat

+44 (0) 207 991 3048

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
POSNKABNABDDOKD
Date   Source Headline
2nd Jun 20262:41 pmRNSHolding(s) in Company
29th May 20264:01 pmRNSTotal Voting Rights
29th May 20264:00 pmRNSNotification of issuance under block listing
27th May 20264:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSIssuance of senior unsecured notes
21st May 20267:00 amRNSHSBC investor and analyst Asia seminar
20th May 20267:00 amRNSHSBC investor and analyst Asia seminar
18th May 20264:20 pmRNSIssuance of perpetual subordinated CC securities
15th May 202611:00 amRNSNotice of redemption and cancellation of listing
12th May 20264:40 pmRNSIssuance of senior unsecured notes (USD)
12th May 20264:05 pmRNSIssuance of senior unsecured notes
12th May 20267:00 amRNSIssuance of perpetual subordinated CCS
8th May 20262:15 pmRNSResult of AGM
8th May 202610:03 amRNSAGM Statements
7th May 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
6th May 202610:00 amRNSBoard and Committee Composition
5th May 202612:30 pmRNSPublication of base prospectus supplement
5th May 20267:00 amRNSEarnings Release 1Q26 Zoom Meeting
5th May 20267:00 amRNSEarnings Release 1Q26
1st May 20264:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:01 pmRNSTotal Voting Rights
30th Apr 20263:00 pmRNSNotification of issuance under block listing
28th Apr 20269:51 amRNSHolding(s) in Company
23rd Apr 202610:00 amRNSNotice of redemption & cancellation of listing
22nd Apr 202610:00 amRNSOverseas Regulatory Announcement - Board Meeting
20th Apr 202612:45 pmRNSFourth Interim Dividend for 2025 - Exchange Rate
17th Apr 20267:00 amRNSAmended and Restated Notice of Redemption
16th Apr 20262:30 pmRNSNotice of redemption
16th Apr 20269:02 amRNSHolding(s) in Company
14th Apr 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
30th Mar 20265:01 pmRNSTotal Voting Rights
30th Mar 20265:00 pmRNSNotification of issuance under block listing
30th Mar 20264:40 pmRNSPublication of base prospectus
27th Mar 20261:30 pmRNSIssuance of senior unsecured notes
27th Mar 20269:00 amRNS2026 AGM - Documents available at NSM
26th Mar 20264:00 pmRNSDirector/PDMR Shareholding
25th Mar 20269:30 amRNSHong Kong Waiver-Contingent Convertible Securities
24th Mar 20264:30 pmRNSDirector/PDMR Shareholding
24th Mar 20263:50 pmRNSIssuance of contingent convertible securities
20th Mar 202611:35 amRNSHolding(s) in Company
20th Mar 202610:56 amRNSHolding(s) in Company
18th Mar 20265:13 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPam Kaur speaks at Investor Conference
18th Mar 20267:00 amRNSIssuance of contingent convertible securities
16th Mar 20269:23 amRNSHolding(s) in Company
16th Mar 20269:23 amRNSHolding(s) in Company
13th Mar 20264:00 pmRNSDirector/PDMR Shareholding
12th Mar 20264:24 pmRNSHolding(s) in Company
12th Mar 20269:00 amRNSGroup reporting changes
12th Mar 20269:00 amRNSGroup reporting changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.